Factor Therapeutics Ltd (ftt) Logo

Factor Therapeutics Ltd (FTT)

___:___ · Healthcare
ASX Delayed
Cboe unavailable

What is live streaming pricing?

Stock prices will auto-update without reloading the page. How it works:

  • Flashing prices signify an increase (green) or decrease (red) from previous price. Otherwise, price is unchanged.
  • Expect a short delay while pricing data initially loads.
  • Note, prices only update during market hours (10am-4:13pm AEST).

More about Cboe Live pricing.

OK, got it
0.00
0.00
(0.00)
VOLUME
DIV YIELD
PE RATIO
1 YR RETURN
52 WEEK RANGE
Overview
Financials

FTT ASX Chart

Snapshot

Factor Therapeutics (FTT, formerly Tissue Therapies Limited) is a clinical-stage life sciences company. It develops treatments for acute and chronic wound healing applications, including chronic skin ulcers and burns. FTT is commercialising VF-001, a technology for cell based therapies. FTT is also developing treatments for psoriasis, scar prevention and various cancers including those of the breast, colon and prostate.

Share Price Activity (ASX)

Last (Price)
Change 0.00 (0.00)
Bid / Ask -
Volume
Volume (4w avg)
Turnover
Open
Day Range -
VWAP
Prev Close
Last Trade

Performance

1 Week
1 Month
2024 YTD
1 Year
vs Sector (1yr) +2.86%
vs ASX 200 (1yr) -7.33%

Size

Market Cap Question Mark Icon
Excludes mandatory escrowed shares and foreign shares.
ASX Rank 2,385 of 2,384
Sector Rank 223 of 227

Key Fundamentals

Shares Issued
Sector Healthcare
Similar Companies TYP / MEQ / AEB
EPS $0.00
DPS $0.00
Book Value Per Share $0.00

Broker Consensus

FTT is not covered by a major broker, or data from most recent compilation was omitted due to not meeting QA guidelines.

Top Market Index News

More News

Announcements

Price Sensitive only

Corporate Overview

Corporate Details

Head Office Brisbane QLD 4000
Website www.factor-therapeutics.com
Registry Link Market Services
Auditor PKF BRISBANE AUDIT
Date Listed 19 Mar 2004

Upcoming Calendar (Forecasted)

Date Event
23/02/2022 Report (Prelim)
23/02/2022 Report (Annual)
27/07/2022 Report (Interim)

Former Company Names

  • Tissue Therapies Limited (TIS), 04/05/2016

Dividend History

DPS and Yield calculations use the Pay Date.

Ex-Date Amount Franking Gross Type Payable
No dividends paid.

See Upcoming Dividends for all ASX companies.

Directors & Management

Directors

Management

Director Transactions

FTT directors must report any change in shareholding to the ASX within 5 business days.

See Director Transactions for all ASX companies.

Date Director Type Amount Price Value Notes
27/09/21 Melanie Farris Issued 204,525 $0.040 $8,181 Director remuneration
27/09/21 David Brookes Issued 500,000 $0.005 $2,500 Issue of options
27/09/21 David Brookes Issued 1,121,250 $0.040 $44,850 Director remuneration
27/09/21 David Brookes Transfer 250,000 $0.005 $1,250 As advised by the company
27/09/21 David Brookes Transfer 250,000 $0.005 $1,250 Off-market transfer
27/09/21 John Michailidis Issued 809,399 $0.040 $32,375 Director remuneration
19/04/18 Cherrell Hirst Issued 474,830 $0.040 $18,993 Rights issue
19/04/18 Christian Behrenbruch Issued 408,164 $0.040 $16,327 Rights issue
19/04/18 John Michailidis Issued 527,432 $0.040 $21,097 Rights issue
17/11/17 John Michailidis Issued 1,000,000 $0.050 $50,000 Issue of options
23/11/16 Robert Ryan Issued 1,000,000 $0.081 $81,000 Issue of options
26/07/16 Christian Behrenbruch Issued 4,000,000 $0.043 $172,000 Issue of options
26/07/16 Christian Behrenbruch Buy +2,857,142 $0.035 $100,000 Placement
26/07/16 Cherrell Hirst Buy +2,857,142 $0.035 $100,000 Placement
26/04/16 Cherrell Hirst Issued 133,334 $0.035 $4,667 Rights issue
04/12/15 Cherrell Hirst Issued 300,000 $0.039 $11,700 Issue of options
04/12/15 Timothy Hughes Issued 300,000 $0.039 $11,700 Issue of options
06/03/15 Steven Mercer Issued 5,000 $0.210 $1,050 Rights issue
06/03/15 Cherrell Hirst Issued 20,834 $0.210 $4,375 Rights issue
06/03/15 Melvyn Bridges Issued 26,691 $0.210 $5,605 Rights issue
06/03/15 Roger Clarke Issued 250,000 $0.210 $52,500 Rights issue
17/06/14 Iain Ross Buy +66,000 $0.290 $19,140 On-market trade
Show All

Director Interests

The current holdings of FTT directors.

Director Last Notice Direct Shares Indirect Shares Options Convertibles
John Michailidis 27/09/2021 0 862,143 100,000 N/A
Melanie Farris 27/09/2021 204,525 N/A 25,000 N/A
David Brookes 27/09/2021 0 1,280,000 500,000 N/A

Shareholder Info

Top 20 Shareholders
About the Data

Data supplied by Morningstar and accurate on Jan 13, 2021.

It's not possible to publish a real-time Top 20 Shareholder list. Companies are not obliged to report this data (with the exception of Substantial Shareholders above 5%). If a company chooses to publish the data, it's usually once a year in their Annual Report.

All data is manually compiled so there might be a delay between the Annual Report being published and the data appearing on Market Index (<7 days for ASX 300 and up to 30 days for micro-caps).

Name Shares Capital
Calama Holdings Pty Ltd 40,000,000 3.84%
GP Securities Pty Ltd 28,607,989 2.74%
Citicorp Nominees Pty Limited 24,261,921 2.33%
Yelwac Pty Ltd 22,594,216 2.17%
Symington Pty Ltd 19,700,000 1.89%
HSBC Custody Nominees (Australia) Limited 16,314,861 1.56%
Mr Jules Christian Wilson 15,099,502 1.45%
Dr Alok Jhamb 15,000,000 1.44%
Mr Francis Xavier Parnis & Mrs Sally Jane Parnis 14,554,598 1.40%
Mr Michael Andrew Whiting & Mrs Tracey Anne Whiting 12,876,085 1.23%
Nurragi Investments Pty Ltd 12,850,000 1.23%
Mr Kevin John Day 12,500,000 1.20%
Mr Konstandinos Emmanouil 12,000,000 1.15%
Harold Cripps Holdings Pty Ltd 11,623,027 1.11%
Mr Anthony Bratton 10,986,115 1.05%
Jetosea Pty Ltd 10,000,000 0.96%
Aglub Investments Pty Ltd 9,945,731 0.95%
Ms Pharoth San & Mr Kaden San 9,500,000 0.91%
Gattenside Pty Ltd 9,033,037 0.87%
Queensland University Of Technology 8,087,010 0.78%

Shareholder Distribution

As reported in the most recent Annual Report.

The most recent Annual Report didn't contain Shareholder Distribution data.

Substantial Shareholders

No Substantial Shareholders for FTT in our database.

Shareholders Buying

12 month transaction history compiled from ASX announcements.

No buy transactions reported by Substantial Shareholders in the past 12 months.

Shareholders Selling

12 month transaction history compiled from ASX announcements.

No sell transactions reported by Substantial Shareholders in the past 12 months.

Historical Data

Share Price History

Date Close Change %Chg Open High Low Volume Turnover

Historical Data

Year Closing Price Last Trade
2021 $0.005 30 June
2020 $0.003 30 June
2019 $0.004 28 June
2018 $0.047 29 June
2017 $0.062 28 June
2016 $0.034 28 June
FTT Historical Price Data (CSV)
Up to 20 years of EOD share price history

Important note:

All year-end and CSV data is "as traded on the day" and ignores corporate actions (e.g. share splits)

Market Index, ASX and Morningstar Logos

All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.